IBIO iBio, Inc. Stock Quote

IBIO [AMEX]

Index	-	P/E	-	EPS (ttm)	-0.83	Insider Own	0.10%	Shs Outstand	216.01M	Perf Week	14.29%
Market Cap	394.98M	Forward P/E	-	EPS next Y	-0.21	Insider Trans	-99.23%	Shs Float	181.60M	Perf Month	43.09%
Income	-41.30M	PEG	-	EPS next Q	-0.04	Inst Own	8.00%	Short Float	6.63%	Perf Quarter	-6.88%
Sales	1.90M	P/S	207.88	EPS this Y	35.40%	Inst Trans	5.77%	Short Ratio	1.02	Perf Half Y	-69.50%
Book/sh	0.49	P/B	3.59	EPS next Y	-10.50%	ROA	-57.00%	Target Price	2.00	Perf Year	473.66%
Cash/sh	0.37	P/C	4.73	EPS next 5Y	-	ROE	-118.00%	52W Range	0.23 - 7.45	Perf YTD	67.62%
Dividend	-	P/FCF	-	EPS past 5Y	8.00%	ROI	-15.60%	52W High	-76.38%	Beta	-6.06
Dividend %	-	Quick Ratio	16.70	Sales past 5Y	-2.40%	Gross Margin	-	52W Low	664.55%	ATR	0.13
Employees	43	Current Ratio	16.80	Sales Q/Q	300.00%	Oper. Margin	-	RSI (14)	67.70	Volatility	7.76% 8.68%
Optionable	Yes	Debt/Eq	0.41	EPS Q/Q	77.40%	Profit Margin	-	Rel Volume	4.32	Prev Close	1.46
Shortable	Yes	LT Debt/Eq	0.40	Earnings	Nov 16 BMO	Payout	-	Avg Volume	11.78M	Price	1.76
Recom	2.00	SMA20	37.61%	SMA50	26.31%	SMA200	-8.80%	Volume	50,852,079	Change	20.55%

Jan-22-21

Initiated

Cantor Fitzgerald

Overweight

Jun-26-20

Initiated

Alliance Global Partners

Buy

$2.55

Jan-22-21 02:02PM	Why iBio Stock Soared Today Motley Fool +20.55%
Dec-28-20 07:30AM	iBio Appoints Dr. Martin B. Brenner as Chief Scientific Officer GlobeNewswire
Dec-10-20 04:30PM	iBio Announces Closing of its Public Offering of Common Stock GlobeNewswire -5.65%
Dec-08-20 08:55AM	iBio Announces Pricing of $35 Million Public Offering of Common Stock GlobeNewswire -12.67%
Dec-07-20 04:01PM	iBio Announces Proposed Public Offering of Common Stock GlobeNewswire
Dec-04-20 11:40AM	Biotech Innovator IBIO Is Down, but Not Out for the Long Term InvestorPlace
Dec-01-20 04:30PM	iBio Selected to Produce ATB Therapeutics Bioengineered Antibody-Toxin Fusion Proteins GlobeNewswire
Nov-27-20 07:10PM	Is iBio, Inc. (IBIO) A Good Stock To Buy? Insider Monkey
Nov-25-20 12:12PM	Its Time for iBio Speculators to Consider Something Else InvestorPlace
Nov-24-20 07:30AM	iBio Announces Issuance of U.S. Patent Covering Endostatin Peptides for Treating Fibrosis GlobeNewswire
Nov-20-20 10:13AM	Stay Away From iBio, Which Constantly Issues Shares to Survive InvestorPlace
Nov-16-20 04:05PM	iBio Reports Fiscal First Quarter 2021 Financial Results and Provides Corporate Update GlobeNewswire +15.17%
Nov-15-20 06:14AM	3 Ultra-Risky Robinhood Stocks That Just Might Make You a Fortune Motley Fool
Nov-13-20 10:48AM	Up 600% Year-to-Date, Sell iBio Stock While Its Still Flying High InvestorPlace
Nov-12-20 08:00AM	iBio to Participate in Alliance Global Partners Virtual Healthcare Symposium GlobeNewswire
Nov-05-20 04:30PM	iBio to Report Fiscal 2021 First Quarter Financial Results and Provide Corporate Update on Monday, November 16 ,2020 GlobeNewswire
Nov-03-20 07:30AM	iBio Announces Appointment of Randy J. Maddux as Chief Operating Officer GlobeNewswire
Oct-29-20 06:29AM	Is It Too Late to Buy iBio Stock? Motley Fool
Oct-15-20 04:05PM	Accomplished Financial Executive, Gary Sender, Joins iBios Board of Directors GlobeNewswire
07:30AM	iBio Announces Appointment of Dr. Alexandra Kropotova to Board of Directors GlobeNewswire
Oct-14-20 04:05PM	iBio Announces Appointment of Dr. Linda Armstrong to Board of Directors GlobeNewswire -8.48%
Oct-13-20 04:05PM	iBio Announces Financial Results for Fiscal Year Ended June 30, 2020 GlobeNewswire +7.69%
Oct-05-20 07:30AM	iBio Regains Compliance with NYSE American Continued Listing Standards GlobeNewswire
Oct-02-20 01:04PM	iBio Will Survive Coronavirus Vaccine Disappointment, But Its not a Buy InvestorPlace
01:04PM	iBio Will Survive Coronavirus Vaccine Disappointment, But Its not a Buy CoinDesk
01:01PM	iBio Is a Pure Spec Play That Remains a Day Traders Delight InvestorPlace
01:01PM	iBio Is a Pure Spec Play That Remains a Day Traders Delight CoinDesk
08:09AM	If Youre Not a Speculator, You Should Avoid iBio InvestorPlace
07:00AM	iBio Enters into Agreement with Safi Biosolutions to Develop Growth Factors and Cytokines Using the FastPharming® System GlobeNewswire
Sep-21-20 02:55PM	IBio is Still Sitting in the Starting Gates of the Vaccine Race InvestorPlace
Sep-18-20 01:58PM	iBio Is a Wishful Thinkers Coronavirus Vaccine Bet InvestorPlace
Sep-09-20 11:58AM	Why iBio Stock Is Soaring Today Motley Fool +5.26%
08:45AM	iBio to Advance COVID-19 LicKM-Subunit Vaccine Candidate, IBIO-201 GlobeNewswire
Sep-03-20 03:29PM	Is CureVac a Buy on the Pullback? It Depends InvestorPlace -7.46%
Aug-28-20 01:58PM	Why iBio Stock Jumped Today Motley Fool
07:15AM	iBio and Planet Biotechnology Enter into Exclusive Worldwide License Agreement for the Development of a COVID-19 Therapeutic GlobeNewswire
05:01AM	Vaccine Race Also-ran iBio Stock Wont See Earlier Highs Anytime Soon InvestorPlace
Aug-24-20 08:42AM	Why ADMA Biologics, iBio, and Kamada Are Jumping Today Motley Fool +30.00%
Aug-19-20 12:52PM	Is iBio's (NYSEMKT:IBIO) 216% Share Price Increase Well Justified? Simply Wall St. -7.72%
Aug-14-20 04:55PM	Xerox and Inozyme See Activist Action Barrons.com
Aug-10-20 07:15AM	iBio Provides Update on IBIO-201 COVID-19 Vaccine Program GlobeNewswire
Jul-20-20 10:17AM	IBio's stock soars, but Novavax and Inovio stocks fall amid news on other COVID-19 vaccine candidates MarketWatch +63.94%
Jul-10-20 03:19PM	A Safer Way to Play IBio Stock Could Spread Like the Coronavirus InvestorPlace
11:24AM	3 Reasons to Invest in, Not Trade iBio InvestorPlace
Jul-02-20 01:56PM	Why iBio Is an Excellent Pandemic Spec Play InvestorPlace -5.77%
Jun-27-20 11:55AM	Coronavirus update: U.S. sets another record for new cases and some states scramble to revisit their reopening plans MarketWatch
Jun-26-20 02:32PM	Coronavirus update: U.S. sets record for new cases in a single day, as Texas becomes first state to reimpose restrictions MarketWatch +33.54%
11:48AM	iBio Is in a Healthy Position With Covid-19 Vaccine Push InvestorPlace
08:18AM	IBio's stock rockets on heavy volume after Russell index inclusion MarketWatch
06:45AM	iBio to be Added to the Russell 2000® and Russell 3000® Indexes GlobeNewswire
Jun-24-20 06:45AM	iBio Selected by IBM Watson Health for the use of IBM Clinical Development Solution at No Cost to help Support clinical COVID-19 Vaccine Candidates GlobeNewswire +6.90%
Jun-18-20 10:50PM	As Insiders Cash Out, Its Time to Sell Moderna Stock InvestorPlace
Jun-05-20 06:01AM	For iBio, the Coronavirus Pandemic Was a Lucky Break InvestorPlace -8.28%
Jun-04-20 07:00AM	iBio Announces Second COVID-19 Vaccine Program GlobeNewswire +8.33%
May-29-20 09:10AM	Slim Vaccine Chances Make iBio Stock Too Speculative Here InvestorPlace
May-27-20 11:45AM	Hedge Funds Have Never Been This Bullish On iBio, Inc. (IBIO) Insider Monkey
May-22-20 09:05AM	7 Top-Rated Biotech Stocks to Buy on the Hunt for a Vaccine InvestorPlace
May-21-20 02:44PM	6 Top-Rated Stocks for a Post-Coronavirus-Crisis Bump InvestorPlace +5.07%
Apr-28-20 03:44PM	Why iBio's Stock Is Trading Higher Today Benzinga +22.26%
Apr-27-20 04:15PM	iBio Estimates ~500 Million Dose Capacity for COVID-19 Vaccine from its FastPharming Facility GlobeNewswire
Apr-24-20 07:00AM	The Coronavirus Makes iBio Finally Relevant InvestorPlace -5.25%
Apr-09-20 07:30AM	iBio Expands COVID-19 Vaccine Collaboration to Include the Infectious Disease Research Institute GlobeNewswire +6.61%
Apr-03-20 05:01AM	IBIO Stock Will Continue to Slide Lower After Speculative COVID-19 Surge InvestorPlace -9.22%
Mar-26-20 04:20PM	iBio Supporting AzarGen Biotechnologies Development of a Rituximab Biosimilar GlobeNewswire +7.14%
07:30AM	iBio Announces Advancement of COVID-19 Vaccine Program GlobeNewswire
Mar-20-20 11:38AM	Dont Waste Time and Risk Capital on Coronavirus Play IBIO Stock InvestorPlace
07:30AM	iBio Joins the Alliance for Biosecurity GlobeNewswire
Mar-18-20 08:00AM	iBio Announces Development of Proprietary COVID-19 Vaccine Candidates GlobeNewswire +40.35%
Mar-13-20 08:08AM	iBio Stock Is Unlikely a Coronavirus Winner and Thus a Real Gamble InvestorPlace +11.89%
Mar-12-20 04:45PM	iBio Announces Leadership Succession, Appoints Thomas F. Isett Co-Chairman & CEO GlobeNewswire -9.49%
Mar-05-20 04:20PM	Dow notches another 900-point loss as benchmark government bond carves out new record low MarketWatch
08:07AM	iBio stock surges 19% premarket on hopes for plans to develop plant-based coronavirus vaccine MarketWatch
Mar-02-20 04:30PM	iBio, Inc. Announces Withdrawal of Proxy Statement Proposal to Amend Its Certificate of Incorporation to Authorize a Possible Reverse Stock Split GlobeNewswire -9.80%
Feb-28-20 10:12AM	iBio shares soar another 174% on hopes for China vaccine partnership MarketWatch +183.24%
Feb-17-20 08:52AM	Here's Why iBio (NYSEMKT:IBIO) Must Play Its Cards Just Right Simply Wall St.
Feb-06-20 04:30PM	iBio, Inc. Announces Postponement of Annual Meeting GlobeNewswire
Feb-04-20 08:54AM	Benzinga Pro's Top 5 Stocks To Watch For Tues., Feb. 4, 2020: GOOGL, DIS, EBAY, F, IBIO Benzinga +61.69%
Feb-03-20 04:15PM	iBio and CC-Pharming Initiate Joint Development of Coronavirus Vaccine GlobeNewswire
Jan-16-20 08:00AM	iBio, Inc. Announces NYSE American Acceptance of Plan of Compliance GlobeNewswire +8.52%
Jan-06-20 09:15AM	iBio Initiates New Litigation Against Fraunhofer GlobeNewswire -11.39%
Dec-23-19 09:30AM	EdgePoint announces collaboration with iBio CDMO to implement AI/Blockchain driven TrustPoint Vision Technology in its Texas cGMP facility GlobeNewswire -9.26%
08:30AM	iBio Announces Collaboration with EdgePoint AI for Next Gen Quality in Biologics Manufacturing GlobeNewswire
Dec-19-19 11:22AM	Is iBio, Inc.'s (NYSEMKT:IBIO) CEO Being Overpaid? Simply Wall St.
Dec-16-19 04:15PM	iBio Reports Progress on its Bio-Better Rituximab Collaboration with CC-Pharming GlobeNewswire -12.89%
Dec-13-19 05:00PM	iBio, Inc. Reports on NYSE American Noncompliance Notice and Compliance Plan GlobeNewswire -7.98%
Dec-10-19 04:44PM	iBio Introduces FastGlycaneering Development Service to Power Recombinant Protein Production GlobeNewswire -9.39%
Dec-03-19 12:31PM	iBio Joins Manufacturing USAs Tissue Biofabrication Initiative GlobeNewswire +41.35%
Dec-02-19 04:15PM	iBio to Present at the First Annual BioTuesdays Pre-JPM Virtual Conference GlobeNewswire +20.04%
Oct-25-19 08:30AM	iBio, Inc. Prices $5,000,000 Public Offering GlobeNewswire -43.26%
Oct-22-19 04:30PM	iBio, Inc. Reports on NYSE American Noncompliance Notice and Compliance Plan GlobeNewswire +15.10%
Sep-19-19 01:58PM	One Thing To Remember About The iBio, Inc. (NYSEMKT:IBIO) Share Price Simply Wall St.
Sep-17-19 04:15PM	iBios Collaboration with South Africas AzarGen Biotechnologies Advances to Next Stage GlobeNewswire
Aug-26-19 05:30PM	iBio and CC-Pharming Expand Business Collaboration in China GlobeNewswire -7.43%
Aug-21-19 12:15PM	A Look At Benzinga Pro's Most-Searched Tickers For August 21, 2019 Benzinga -7.87%
Aug-19-19 04:35PM	iBio Inks 3D Bioprinting Agreement GlobeNewswire
Jul-25-19 11:16AM	Did Changing Sentiment Drive iBio's (NYSEMKT:IBIO) Share Price Down A Painful 89%? Simply Wall St.
Jun-19-19 08:00AM	iBio Announces First Agreement for Fill-Finish Services GlobeNewswire
Jun-10-19 01:58PM	How Should Investors React To iBio, Inc.'s (NYSEMKT:IBIO) CEO Pay? Simply Wall St.
Jun-03-19 08:00AM	iBio Launches New Sterile Fill-Finish Services GlobeNewswire
Apr-24-19 02:03PM	What Type Of Shareholder Owns iBio, Inc.'s (NYSEMKT:IBIO)? Simply Wall St.

iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for the treatment of systemic scleroderma, idiopathic pulmonary fibrosis, and related conditions. The company is also developing vaccine candidates comprising IBIO-200 and IBIO-201, which are in preclinical development for the prevention of severe acute respiratory syndrome coronavirus 2; and IBIO-400 for the treatment of classical swine fever. In addition, it is developing recombinant proteins for third parties on a catalog and custom basis; and offers a range of process development, manufacturing, filling and finishing, and bio analytic services. iBio, Inc. has a license agreement with Planet Biotechnology, Inc. to develop therapeutics for infectious diseases; collaboration agreement with AzarGen Biotechnologies (Pty) Ltd (AzarGen) for the contract development and manufacturing services for AzarGen's development of a rituximab biosimilar/biobetter for the South African market; collaboration agreement with The Texas A&M University System for the development of coronavirus disease 2019 vaccine candidates; license agreement with the University of Natural Resources and Life Sciences, Vienna; collaboration with EdgePoint AI, a division of Mateon Therapeutics, Inc.; and collaboration agreement with CC-Pharming Ltd. iBio, Inc. is headquartered in New York, New York.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Eastern Capital LTD	10% Owner	Aug 11	Sale	2.92	15,864,436	46,330,499	8,629,693	Aug 11 05:08 PM
Eastern Capital LTD	10% Owner	Aug 10	Sale	3.91	7,264,864	28,429,592	24,494,129	Aug 11 05:08 PM
Eastern Capital LTD	10% Owner	Aug 07	Sale	3.83	1,355,604	5,185,592	31,758,993	Aug 11 05:08 PM
Eastern Capital LTD	10% Owner	Aug 06	Sale	4.18	2,768,137	11,570,536	33,114,597	Aug 06 05:33 PM
Eastern Capital LTD	10% Owner	Aug 05	Sale	4.46	900,000	4,013,550	35,882,734	Aug 06 05:33 PM
Eastern Capital LTD	10% Owner	Aug 04	Sale	4.39	600,000	2,636,640	36,782,734	Aug 06 05:33 PM
ERWIN ROBERT L	President	Jun 04	Option Exercise	0.93	28,268	26,289	108,108	Jun 08 12:41 PM
ERWIN ROBERT L	President	Jun 04	Sale	1.71	28,268	48,338	108,108	Jun 08 12:41 PM
ERWIN ROBERT L	President	Jun 02	Option Exercise	0.93	96,124	89,395	136,376	Jun 05 06:04 AM
ERWIN ROBERT L	President	Jun 02	Sale	1.62	96,124	155,721	136,376	Jun 05 06:04 AM
Mullaney James P.	Chief Financial Officer	May 27	Option Exercise	0.93	11,250	10,463	0	May 29 12:45 PM
Mullaney James P.	Chief Financial Officer	May 27	Sale	1.61	11,250	18,113	0	May 29 12:45 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience